Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6 on the Study Details page, signaling a new version of the page rather than a change to study data.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe 2025-05-20 entry and the Certification/Extension First Posted label were removed from the Study Record Dates, updating the page's historical QC metadata rather than the trial details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page. There are no user-facing content changes detected in this update.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4. This indicates a new revision of the page content or site template, without altering core study information.SummaryDifference0.0%

- Check72 days agoChange Detected- The page revision was updated from v3.6.2 to v3.6.3, indicating a new revision entry in the page history. This appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.SummaryDifference0.0%

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.